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Abstract
Background
The association between body mass index (BMI) and cognitive function is a public health
issue. This study investigated the relationship between obesity and cognitive impairment
which was assessed by the Korean version of the Mini-mental state examination (K-MMSE)
among mid- and old-aged people in South Korea.
Methods
A cohort of 5,125 adults, age 45 or older with normal cognitive function (K-MMSE24) at
baseline (2006), was derived from the Korean Longitudinal Study of Aging (KLoSA)
2006~2012. The association between baseline BMI and risk of cognitive impairment was
assessed using multiple logistic regression models. We also assessed baseline BMI and
change of cognitive function over the 6-year follow-up using multiple linear regressions.
Results
During the follow-up, 358 cases of severe cognitive impairment were identified. Those with
baseline BMI25 kg/m2 than normal-weight (18.5BMI<23 kg/m2) were marginally less likely
to experience the development of severe cognitive impairment (adjusted odds ratio [aOR] =
0.73, 95%CI = 0.52 to 1.03; Ptrend = 0.03). This relationship was stronger among female (aOR
= 0.63, 95%CI = 0.40 to 1.00; Ptrend = 0.01) and participants with low-normal K-MMSE score
(MMSE: 24–26) at baseline (aOR = 0.59, 95%CI = 0.35 to 0.98; Ptrend<0.01). In addition, a
slower decline of cognitive function was observed in obese individuals than those with normal
weight, especially among women and those with low-normal K-MMSE score at baseline.
Conclusion
In this nationally representative study, we found that obesity was associated with lower risk
of cognitive decline among mid- and old-age population.
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Introduction
Overweight and obese individuals are known to be at a higher risk for dementia [1–8]. Adipos-
ity may be directly and indirectly, by increasing other vascular risk factors, linked to cognitive
impairment and dementia [9]. Nevertheless, the association between body mass index (BMI)
and risk of dementia is far from clear. In late life, the detrimental consequences of being obese
or overweight appear less apparent, and there are even potential protective effects. For example,
individuals with high BMI (BMI25 kg/m2) have been observed to have a lower risk of cogni-
tive impairment [10–16]. Furthermore, a recent study based on a large population, almost two
million, reports an inverse association between BMI and the risk of dementia in both mid- and
late-life [17]. There is continuing controversy regarding the protective effects or detrimental
effects of a high BMI.
The number of reported cases of dementia is rapidly increasing in Asia. By 2050, the preva-
lence will increase three times, and more than half of people worldwide living with dementia
will live in the Asia Pacific region [18]. In particular, as Asians tend to have higher amounts of
abdominal fat at lower BMIs [19], an alternative definition of overweight (BMI 23.0–24.9 kg/
m2) and obesity (BMI25 kg/m2) has been proposed for Asian populations [20]. For example,
mortality risks significantly increased at BMI25 kg/m2, rather than at BMI30 kg/m2 [21].
In addition, an examination of racial and ethnic differences among older adults found that the
positive association of obesity with cognitive performance appeared only in Whites, and there
were negative associations in Hispanics and Blacks [22]. However, while most of the existing
literature has been based on western countries, the causal role of BMI as a risk factor for cogni-
tive impairment among middle-and old-age individuals in Asian countries has rarely been
investigated. Although one particular study from Asia found that obese adults experienced
slower cognitive decline, it was quite small (based on fewer than 800 subjects) and short in
duration of follow-up (2 years) [23]. Thus, it is unclear whether or not there is a protective
association between high BMI and cognitive impairment in Asian populations.
Meanwhile, some factors may affect associations between BMI and cognitive function. For
example, vascular risk factors are related to both dementia and depression [24]. Individuals
with depression experience faster cognitive decline and high risk of dementia, [25–28] and also
have a greater risk of vascular and neurological outcomes [29, 30], myocardial infarction and
coronary heart disease [31, 32], and stroke [33, 34]. In addition, a meta-analysis showed a
reciprocal positive association between obesity and depression [35] while obesity is known as a
risk factor for neurobiological diseases like stroke [36, 37]. Since there might be interactions
between risk factors, it could be worthwhile to examine whether the relations of obesity to cog-
nitive function depends on other factors.
More research would be needed to better understand the relationships between obesity and
cognitive impairment in Asian countries. This research investigated how BMI relates to cogni-
tive impairment/decline in middle- and old-aged people with healthy cognitive function, using
a nationally representative longitudinal sample of South Korean middle and old-aged adults.
Methods
Study population and source of data
The present study used data from the Korean Longitudinal Study of Aging (KLoSA), which is a
nationally representative panel survey on middle- and old-aged populations (over 45), admin-
istered, since 2006, by the Korea Labor Institute [38]. A total of 6,171 households were sampled
from 1,000 sample enumeration districts. Through the computer assisted personal interviewing
procedure, data on demographics, family structure, health status, medical history, income and
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employment status for 10,254 individuals aged 45 years or older were collected in 2006 and fol-
lowed-up with for every even-numbered year. Of four publicly available waves (2006, 8, 10,
and 12), we used the first and fourth waves. Of the 10,254 eligible population, for whom cogni-
tive function is measured at baseline, 7,299 individuals with normal cognitive function (the
Korean version of the Mini-mental state examination, K-MMSE>23) were defined as the base-
line study population [39]. 52 participants with missing values for weight and height were
excluded from the first wave, and 2,122 individuals were additionally excluded from the fourth
wave (326 due to death, 1,423 due to non-response, and 373 due to missing values for relevant
variables). Therefore, we set our analytic sample as the remaining 5,125 respondents (Fig 1).
Measurements
The study considered a twofold dependent variable, which was measured by using the
K-MMSE.: 1) onset of severe cognitive impairment; and 2) the extent of decline in cognitive
functions over a six-year follow-up period. The K-MMSE included 11 items in 7 categories of
cognitive functions, including orientation for time and place, registration, attention & calcula-
tion, recall, language, and visual construction [39, 40]. The total score of the measure ranges
from 0 to 30; the higher the score, the better the cognitive function. The validity of the
K-MMSE was reported elsewhere [40]. We followed the conventional classification criteria
for cognitive function, categorizing K-MMSE scores as severe cognitive impairment (SCI,
K-MMSE17), mild cognitive impairment (MCI, 18K-MMSE23), and normal cognitive
function (K-MMSE24) [39, 40].
BMI (kg/m2) was estimated from self-reported weight and height in 2006, and was classified
as underweight (BMI<18.5), normal (18.5BMI<23), overweight (23BMI<25), and obese
(BMI25) according to the revised Asia-Pacific BMI criteria by the World Health Organiza-
tion Western Pacific Region [20]. A validation study of the self-reported measure using a sub-
sample (N = 510) of KLoSA reported that there was an adequate degree of correlation between
self-reported and measured BMI values (Pearson’s correlation coefficient 0.837 for men, and
0.865 for women) [41].
From the first wave, other covariates were collected: age (45–54, 55–64,65 years), sex,
marital status (married, unmarried), education (elementary, middle, high school, and
college), equivalized household income (quartile), insurance status (Medicaid vs National
Health Insurance), residence (urban, rural), cigarette smoking (yes, no), alcohol consumption
(yes, no), regular physical activity (more than once a week, no), activities of daily livings (0,
1), depression (the Center for Epidemiologic Studies-Depression 10-item Scale4,<4), and
comorbidity (at least one of hypertension, diabetes, cardiovascular disease, and/or cerebrovas-
cular disease, 0).
Statistical analysis
To investigate the association between BMI and cognitive impairment, we used two approaches
in framing the outcome: 1) new-onset of SCI after 6 years’ follow-up as a binary outcome
(K-MMSE17), and 2) cognitive decline on a continuous scale by using the change in
K-MMSE scores from 2006 to 2012. As our primary approach, for the association between
baseline body weight status and new-onset of SCI, we performed multiple logistic regressions
for the selected analytic sample and estimated adjusted Odds Ratios (aORs). Additionally, the
association between baseline body weight status and cognitive decline (change in K-MMSE
scores) was assessed using multiple linear regression, and adjusted means of change were esti-
mated. For both logistic and linear models, sets of covariates were sequentially included as fol-
lows: Model 1 (age, gender), Model 2 (marital status, health insurance, income, education,
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place of living, based on Model 1), Model 3 (physical activity, drinking, and smoking, based on
Model 2), and Model 4 (comorbidity, activities of daily livings, depression, and baseline
K-MMSE). We set Model 4 as the final model for both outcomes.
After investigating the overall impact of baseline BMI on change in cognitive function at fol-
low-up, we performed stratified analyses by age, gender, baseline K-MMSE score (24–26,27),
smoking, drinking, physical activity, depression and comorbidity status in order to figure out
the potentially differential impact of weight status on cognitive decline across the subgroups.
We applied longitudinal sampling weight, and adjusted for complex survey design by account-
ing for strata and cluster. For all analyses, we used Stata ver 12.0 and set the level of significance
as 0.05 (two-sided).
The study was conducted in accordance with the Ethical Principles for Medical Research
Involving Human Subjects, as defined by the Helsinki Declaration. Participants were required
to read and sign an agreement form before participating in the KLoSA study. For the present
study, the Institutional Review Board of Seoul National University Hospital (South Korea)
waved institutional review board approval because this study used only publicly available de-
identified data.
Results
Table 1 presented the baseline characteristics of the study population. Among the total of 5,125
subjects, 24.6% were obese, 31.5% overweight, 41.7% normal weight, and 2.2% underweight.
Across the age groups (45–54, 55–64, 65+), the oldest group (age65) had the smallest propor-
tions of obese (22.7%) and overweight (30.9%) individuals, while the group had the largest pro-
portion of underweight (3.2%) and normal-weight (43.2%) individuals. Interestingly, the
proportions of obese/overweight individuals were greater among those who had regular physi-
cal activity (26.9% for obese, 32.2% for overweight) than those who did not (22.8% for obese,
30.9% for overweight). Furthermore, the proportions of obese/overweight individuals were sig-
nificantly greater among those who had chronic disease (35.5% vs. 20.5% for obese, 32.4% vs.
31.1% for overweight) and were depressed (24.8% vs. 24.0% for obese, 32.6% vs. 27.4% for
overweight).
Tables 2 and 3 displayed the results from the multiple logistic regression models for the
association between baseline BMI and new-onset of SCI after the six year follow-up. Overall,
Fig 1. Schematic diagram of the study population.
doi:10.1371/journal.pone.0148908.g001
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Table 1. General characteristics of study population.
Overall BMI<18.5 18.5~23 23~25 25+ p-value
n = Weighted% n = Weighted% n = Weighted% n = Weighted% n = Weighted%
General Information 5,125 100.0 116 2.2 2,169 41.7 1,599 31.5 1,241 24.6
Age (years)
45–54 2,127 55.9 36 1.8 936 42.6 642 31.1 513 24.5 0.06
55–64 1,674 28.6 38 2.5 654 39.1 554 32.5 428 25.9
65+ 1,324 15.6 42 3.2 579 43.2 403 30.9 300 22.7
Sex
Male 2,515 51.3 56 1.9 1,034 39.6 840 34.3 585 24.1 <0.01
Female 2,610 48.7 60 2.5 1,135 43.9 759 28.5 656 25.2
Marital status
Married 4,492 88.5 91 2.0 1,919 42.0 1,397 31.4 1085 24.6 0.08
Unmarried 633 11.5 25 3.8 250 39.8 202 31.7 156 24.7
Education
Elementary School 399 5.7 19 5.1 184 44.8 104 25.5 92 24.7 <0.01
Middle School 1,320 21.8 33 2.3 528 39.6 397 30.2 362 28.0
High School 1,011 19.8 19 1.9 405 39.6 336 32.5 251 26.0
College+ 2,395 52.7 45 2.0 1,052 43.1 762 32.2 536 22.7
Household income
1Q 1,305 22.4 52 4.0 552 41.6 399 31.4 302 23.1 <0.01
2Q 1,262 23.5 21 1.7 523 40.1 375 29.9 343 28.3
3Q 1,391 28.4 26 2.0 563 39.7 479 35.1 323 23.2
4Q 1,167 25.7 17 1.4 531 45.5 346 29.0 273 24.2
Insurance
Medicaid 203 3.9 9 3.7 80 40.9 56 27.1 58 28.4 0.33
National Health Insurance 4,922 96.1 107 2.2 2,089 41.7 1,543 31.7 1183 24.5
Location
Urban 3,943 79.9 89 2.2 1,615 40.7 1,259 31.9 980 25.2 0.06
Rural 1,182 20.1 27 2.1 554 45.8 340 29.6 261 22.4
Cigarette smoking
No 3,505 66.5 72 2.3 1,488 42.2 1,065 30.2 880 25.3 0.09
Yes 1,620 33.5 44 2.1 681 40.7 534 34.0 361 23.2
Alcohol consumption
No 2,909 52.7 71 2.4 1,245 42.6 884 30.2 709 24.9 0.27
Yes 2,216 47.3 45 2.0 924 40.7 715 32.9 532 24.3
Physical Activity
Yes 2,262 43.9 35 1.4 914 39.4 724 32.2 589 26.9 <0.01
No 2,863 56.1 81 2.8 1,255 43.5 875 30.9 652 22.8
Activities of daily livings
0 5,084 99.3 116 2.2 2,152 41.7 1,589 31.5 1227 24.5 0.31
1+ 41 0.7 0 0.0 17 36.5 10 25.4 14 38.1
Depressiona
Yes 3,919 78.5 77 1.9 1,634 40.7 1,253 32.6 955 24.8 <0.01
No 1,206 21.5 39 3.3 535 45.3 346 27.4 286 24.0
Comorbidityb
0 3,555 72.6 85 2.3 1,676 46.1 1,085 31.1 709 20.5 <0.01
+1 1,570 27.4 31 2.0 493 30.1 514 32.4 532 35.5
a The Center for Epidemiologic Studies-Depression 10-item Scale4 (Yes), <4 (No).
b Hypertension, diabetes, cardiovascular disease, or cerebrovascular diseases.
doi:10.1371/journal.pone.0148908.t001
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Table 2. Adjusted Odd Ratios of baseline bodymass index for severe cognitive impairment in Korean adults 45+ years.
Baseline body mass index
<18.5 18.5~23 23~25 25+ p for trend
All (n = 16) (n = 166) (n = 110) (n = 66)
Model 1 1.55 1.00 0.87 0.78 0.05
(95% CI) a (0.85–2.83) (0.66–1.15) (0.56–1.09)
Model 2 1.42 1.00 0.88 0.76 0.04
(95% CI) b (0.76–2.64) (0.66–1.16) (0.54–1.07)
Model 3 1.42 1.00 0.88 0.76 0.04
(95% CI) c (0.76–2.65) (0.66–1.15) (0.54–1.06)
Model 4 1.44 1.00 0.87 0.73 0.03
(95% CI) d (0.78–2.68) (0.66–1.15) (0.52–1.03)
Men (n = 7) (n = 79) (n = 53) (n = 33)
Model 1 1.27 1.00 0.84 0.86 0.38
(95% CI) a (0.54–2.98) (0.56–1.28) (0.53–1.39)
Model 2 1.18 1.00 0.86 0.86 0.43
(95% CI) b (0.48–2.90) (0.56–1.31) (0.53–1.41)
Model 3 1.18 1.00 0.86 0.86 0.43
(95% CI) c (0.49–2.87) (0.57–1.31) (0.52–1.41)
Model 4 1.21 1.00 0.86 0.83 0.38
(95% CI) d (0.50–2.91) (0.56–1.32) (0.49–1.41)
Women (n = 9) (n = 87) (n = 57) (n = 33)
Model 1 1.88 1.00 0.87 0.68 0.03
(95% CI) a (0.84–4.20) (0.60–1.25) (0.43–1.06)
Model 2 1.80 1.00 0.88 0.66 0.03
(95% CI) b (0.79–4.10) (0.61–1.27) (0.42–1.05)
Model 3 1.74 1.00 0.89 0.66 0.03
(95% CI) c (0.75–4.04) (0.61–1.28) (0.42–1.05)
Model 4 1.77 1.00 0.87 0.63* 0.01
(95% CI) d (0.77–4.05) (0.60–1.27) (0.40–1.00)
Baseline K-MMSE:24–26 (n = 6) (n = 92) (n = 67) (n = 42)
Model 1 2.50* 1.00 0.71 0.71 0.02
(95% CI) a (1.07–5.88) (0.46–1.09) (0.43–1.16)
Model 2 2.26 1.00 0.73 0.69 0.03
(95% CI) b (0.93–5.49) (0.47–1.13) (0.41–1.15)
Model 3 2.14 1.00 0.72 0.69 0.03
(95% CI) c (0.87–5.29) (0.46–1.12) (0.41–1.16)
Model 4 2.20 1.00 0.67 0.59* <0.01
(95% CI) d (0.87–5.57) (0.43–1.05) (0.35–0.98)
Baseline K-MMSE:27–30 (n = 10) (n = 74) (n = 43) (n = 24)
Model 1 0.96 1.00 0.97 0.82 0.38
(95% CI) a (0.39–2.35) (0.69–1.37) (0.54–1.25)
Model 2 0.93 1.00 0.97 0.80 0.34
(95% CI) b (0.37–2.31) (0.69–1.38) (0.52–1.23)
Model 3 0.94 1.00 0.97 0.79 0.30
(95% CI) c (0.38–2.35) (0.68–1.37) (0.52–1.21)
Model 4 0.95 1.00 0.98 0.80 0.36
(Continued)
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there was no statistically significant evidence that either being overweight or underweight in
2006 were associated with increased/decreased risk of SCI. However, though not statistically
significant, when compared with normal weight, the point estimates of aORs for underweight
(aOR = 1.44, 95% CI: 0.74, 2.68), overweight (aOR = 0.87, 95% CI: 0.66, 1.15), and obese
(aOR = 0.73, 95% CI: 0.52, 1.03) categories showed a linear trend in the risk of SCI after the six
year follow-up across weight status at baseline (p for trend = 0.03).
A significant association between weight status and the new-onset of SCI was found in some
subgroups. When stratified by gender, women with obesity in 2006 showed significantly lower
risk of SCI (aOR = 0.63, 95% CI: 0.40, 1.00) compared with women with normal weight.
Though statistically not significant, the directionalities of point estimates of aORs among each
gender group were consistent with the result from overall analysis. Particularly, the linear trend
in the association between weight status and risk of SCI was more apparent among women (p
for trend = 0.01) than among men (p for trend = 0.38). Among those with lower normal cogni-
tive function (24K-MMSE26), obesity was associated with lower risk of SCI when com-
pared to normal weight (aOR = 0.59, 95% CI: 0.35, 0.98) with notable linear trend of the risk of
SCI across weight status (p for trend<0.01) (Table 2).
When looking at the results from the subgroup analyses in Table 3, among older adults
(age65), obesity at baseline was associated with lower risk of SCI at 6 years’ follow-up and a
significant linear trend in the association between weight status and the new-onset of SCI
(p = 0.004). When stratified by drinking status, current drinkers with obesity showed signifi-
cantly smaller risk of SCI, compared to current drinkers with normal weight (aOR = 0.49, 95%
CI: 0.27, 0.88). In addition, currently non-drinking status paired with underweight status was
associated with a greater risk of SCI, compared to non-drinking paired with normal weight
(aOR = 2.47, 95% CI: 1.21, 5.05).
Fig 2 presented the results from the multiple linear regression models for the association
between baseline BMI and change in cognitive function as a continuous scale over the six-year
follow-up. Among all individuals, being obese at baseline appeared to be related to a slower
decline in cognitive function over the following six years, compared to individuals with normal
weight. When stratified by gender, women with obesity showed, on average, a smaller decrease
in K-MMSE score (beta = 0.6, 95% CI: 0.04, 1.16, p = 0.04) than women with normal weight at
baseline. Among individuals with lower normal cognitive function (24K-MMSE26) at base-
line, compared with higher normal cognitive function, being overweight and obese showed a
Table 2. (Continued)
Baseline body mass index
<18.5 18.5~23 23~25 25+ p for trend
(95% CI) d (0.38–2.35) (0.69–1.39) (0.52–1.24)
Abbreviations: K-MMSE, the Korean version of the Mini-mental state examination; CI, conﬁdence interval.
* p < .05.
n = number of cases of severe cognitive impairment (K-MMSE  17 in 2012)
Baseline body mass index was estimated from the 2006 survey.
a Adjusted for gender and age from the 2006 survey.
b Based on model 1, model 2 was further adjusted for marital status, health insurance, income, educational level, and living place from the 2006 survey.
c Based on model 2, model 3 was further adjusted for physical activity, drinking, and smoking status from the 2006 survey.
d Based on model 3, model 4 was further adjusted for comorbidity, baseline K-MMSE score, activities of daily livings and depression from the 2006
survey.
doi:10.1371/journal.pone.0148908.t002
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Table 3. Adjusted Odd Ratios of baseline bodymass index for severe cognitive impairment by demographic and behavioral factors in Korean
adults 45+ years.
Baseline body mass index
<18.5 18.5~23 23~25 >25 p for trend
Ever smoker (n = 5) (n = 60) (n = 25) (n = 20)
adjusted OR 0.88 1.00 0.50* 0.62 0.06
(95% CI) (0.29–2.66) (0.29–0.87) (0.33–1.16)
Never smoker (n = 11) (n = 106) (n = 85) (n = 46)
adjusted OR 1.90 1.00 1.11 0.79 0.14
(95% CI) (0.94–3.86) (0.80–1.55) (0.53–1.19)
Current drinking (n = 2) (n = 70) (n = 35) (n = 23)
adjusted OR 0.46 1.00 0.65 0.49* 0.02
(95% CI) (0.10–2.15) (0.41–1.03) (0.27–0.88)
No drinking (n = 14) (n = 96) (n = 75) (n = 43)
adjusted OR 2.47* 1.00 1.10 0.98 0.41
(95% CI) (1.21–5.05) (0.79–1.55) (0.65–1.49)
No physical activity (n = 11) (n = 100) (n = 69) (n = 33)
adjusted OR 1.46 1.00 1.04 0.72 0.10
(95% CI) (0.68–3.13) (0.74–1.46) (0.46–1.13)
Physical activity (n = 5) (n = 66) (n = 41) (n = 33)
adjusted OR 1.45 1.00 0.68 0.75 0.22
(95% CI) (0.51–4.12) (0.43–1.10) (0.40–1.39)
Age  65 (n = 10) (n = 86) (n = 58) (n = 28)
adjusted OR 2.02 1.00 0.94 0.56* <0.01
(95% CI) (0.86–4.75) (0.64–1.38) (0.35–0.92)
Age <65 (n = 6) (n = 80) (n = 52) (n = 38)
adjusted OR 1.14 1.00 0.81 0.78 0.19
(95% CI) (0.46–2.84) (0.55–1.18) (0.50–1.21)
No depression (n = 7) (n = 102) (n = 71) (n = 52)
adjusted OR 0.88 1.00 0.86 0.86 0.44
(95% CI) (0.39–2.01) (0.60–1.23) (0.58–1.28)
Depression (n = 9) (n = 64) (n = 39) (n = 14)
adjusted OR 2.31 1.00 0.90 0.42* <0.01
(95% CI) (0.90–5.96) (0.56–1.45) (0.21–0.86)
Comorbidity: 0 (n = 11) (n = 112) (n = 63) (n = 32)
adjusted OR 1.59 1.00 0.91 0.82 0.18
(95% CI) (0.78–3.24) (0.64–1.29) (0.53–1.28)
Comorbidity: 1+ (n = 5) (n = 54) (n = 47) (n = 34)
adjusted OR 1.15 1.00 0.80 0.60* 0.04
(95% CI) (0.38–3.49) (0.50–1.26) (0.36–1.00)
Abbreviations: K-MMSE, the Korean version of the Mini-mental state examination; OR, Odds Ratio; CI, conﬁdence interval.
* p < .05.
n = number of cases of severe cognitive impairment (K-MMSE  17 in 2012).
Baseline body mass index was estimated from the 2006 survey. Age, gender, marital status, health insurance, income, educational level, living place,
physical activity, smoking status, drinking status, comorbidity, activities of daily livings, depression, and baseline K-MMSE score from the 2006 survey
were adjusted for.
doi:10.1371/journal.pone.0148908.t003
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significantly smaller cognitive decline (beta for overweight = 0.80, 95% CI: 0.02, 1.58, p = 0.04;
beta for obesity = 0.88, 95% CI: 0.06, 1.69, p = 0.04) (Fig 2).
Discussion
In this nationally representative study, we provide the prospective investigation of BMI and
decline of cognitive function. Our results suggest that being obese (BMI25 kg/m2), especially
Fig 2. Adjusted mean of change of K-MMSE score across baseline bodymass index in Korean adults
45+ years. Abbreviations: K-MMSE, the Korean version of the Mini-mental state examination. Reference
category: body mass index 18.5–23 kg/m2. * p < .05 ** p < .01, *** p < .001. Change of K-MMSE score was
calculated by subtracting 2006 K-MMSE from 2012 K-MMSE. Baseline BMI was measured from the 2006
survey. Age, gender, marital status, health insurance, income, educational level, living place, physical
activity, smoking and drinking status, comorbidity, activities of daily livings, depression, and baseline
K-MMSE score from the 2006 survey were adjusted for.
doi:10.1371/journal.pone.0148908.g002
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in late-life, is related to a lower risk of cognitive impairment, compared with having a normal
weight (18.5BMI<23 kg/m2). This relationship became stronger when we adjusted for con-
founding factors, such as health behavior and health status. We also found that, although cog-
nitive function decreased over the follow-up period, obese individuals, as compared to those
with normal weight, experienced a slower decline in cognitive function. In addition, the protec-
tive association of high BMI with cognitive performance was more prominent in women and
individuals with relatively low-normal K-MMSE score at baseline.
The protective association of obesity (BMI25 kg/m2) with cognitive function observed in
the present study is broadly consistent with previous studies in western countries. Whereas
positive association between obesity and cognitive impairment is generally expected, protective
effects, rather than detrimental consequences, of a high BMI on cognitive function has often
been observed, especially during old age. Older persons with high BMI scores (i.e. BMI25) at
baseline have less risk of dementia [1–8, 15, 42], and experience slower declines in cognitive
function [12]. In addition, Qizilbash and colleagues [17] found inverse associations between
BMI and dementia, even in mid-life, based on almost 2 million primary care patients in the
UK. Another study analyzing data from the Whitehall study replicated the same results [43].
Our results showed the protective association of high BMI with cognitive impairment among
adults 65 years and older. When the sample was restricted to adults 45–65 years, the protective
association was not statistically significant, and the protective relationship between high BMI
and cognitive function became more evident among adults age 65 or older. Although weight
loss that seemingly begins years before the onset of clinical syndrome of dementia may be
related to these findings [44], it would not completely account for those associations. For
instance, according to a previous study, individuals whose BMI was high (25–30) over the past
four years experienced lower cognitive impairment than those with consistent normal range
(20–25) of BMI [11]. Furthermore, a study with a 26-year follow-up period reported that high
late-life BMI was associated with lower risk of Alzheimer’s disease (0.89, 0.81–0.98) and mar-
ginally significant association with lower onset of dementia [7]. That is, although being under-
weight and losing weight may be an early marker of cognitive impairment [7, 11, 44], high BMI
scores during old age tend to have consistently a protective association with cognitive function.
Meanwhile, in the present study, being underweight (BMI<18.5) rarely shows statistically
significant associations with the development of cognitive impairment, contrary to previous
findings. This is probably due to the fact that in middle- and old-age populations, being under-
weight has a high mortality risk [45], so cognitive impairment is possibly underestimated in
the group. In addition, this study restricted the sample population to individuals with a normal
range of K-MMSE scores at baseline, which in turn led the group of underweight individuals to
lose more samples than other groups. Indeed, the number of underweight individuals at base-
line was the smaller (n = 116, 2.2%) than the other weight groups.
Relationships between high BMI and cognitive impairment have been explained since adi-
posity is directly related to hyperinsulinemia, adipokines and cytokines, and indirectly related
to vascular risk factors [9]. It is plausible that the role of BMI in dementia may change over the
course of life. That is, the cut-off distinguishing underweight from normal conditions may dif-
fer in the elderly and younger populations. For example, for older people, similarly to the pro-
tective association of high BMI with cognitive function observed, the detrimental effects of
high BMI on mortality are attenuated with increasing age [46], and a BMI lower than 25 corre-
lates with a higher risk of death [47]. In addition, previous studies suggest that a BMI of less
than 25 may be indicative of malnutrition for older people while nutritional and cognitive sta-
tus correlates closely via the fat brain axis [48, 49].
The protective associations of high BMI with cognitive impairment might be related to
changes in body composition. Aging is characterized by the loss of lean body mass [46], and
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higher lean body mass may be involved in reducing the risk of cognitive impairment in an
older population [50]. Furthermore, high BMI may also result from increased accumulation of
fat in regions other than the abdominal area. Larger leg fat mass in older individuals has been
associated with improved glucose metabolism [51], which could potentially contribute to a
lower risk of development of cognitive impairment. In addition, the association might be medi-
ated by serum urate, which is positively correlated with BMI and, by acting as antioxidants in
the brain, might prohibit development of neurodegenerative disease [52, 53]. Further bio-
marker studies are needed to clarify the relationship and mechanisms.
The present study has several limitations. First, obesity was assessed based on self-reported
body weight and height in KLoSA, which can lead to biased estimates. However, the validation
study reported adequate degree of correlation between self-reported and measured BMI data
(Pearson’s correlation: 0.84 for men, and 0.87 for women) [41]. In addition, in our modeling
approach, we adjusted factors that were associated with the discrepancy in BMI measures from
the validation study, including region, age, and educational level, as well as other covariates
such as chronic disease histories and activities of daily livings. Second, the disagreement in
BMI measures may be associated with cognitive function, which could bias the findings of the
present study. However, we excluded participants with lower than normal range of K-MMSE
score at baseline. Third, selection bias due to differential loss to follow-up can be an issue.
Among 7,247 participants with normal cognitive function in 2006, 29% were not included in
the analysis due to death (n = 326), non-responses due to reasons other than death (n = 1,423),
and missing values (n = 373). However, the mean values of K-MMSE score at baseline were
similar between the study population (mean K-MMSE score = 27.36 for N = 5,125) and those
who dropped out (mean score = 27.42 for N = 2,122) over the follow-up. Therefore, it is possi-
ble that the potential issue of attrition of this study might not have influenced the findings of
the present study. Lastly, the residuals of linear regressions for MMSE change did not appear
normally distributed when the Kolmogorov Smirnov test were used. Although analysis based
on log-transformation showed consistent results (i.e., There were the significantly positive
associations of obesity with MMSE change among women and adults with low-normal
K-MMSE score at baseline) (results not shown), the findings for MMSE changes should be
interpreted more carefully.
Despite the limitations, there are several strengths of this study. Most of all, we used a
nationally representative panel survey, which enables us to investigate a causal relationship
between weight status to cognitive impairment/decline. To our knowledge, this is the first
study that provides statistically reliable and robust evidence for an association between BMI
with cognitive performance among middle- and old-age population in the region of Asia where
the rate of aging-related diseases is rapidly increasing. In addition, we employed two outcome
measures, both new-onset of severe cognitive impairment and cognitive decline over the fol-
low-up, which provided consistent findings. Furthermore, we excluded individuals with mild
to severe cognitive impairment (K-MMSE23) at baseline, and adjusted for a wide range of
potential confounders including health-related behaviors and health status such as drinking,
smoking, physical activity, activities of daily livings, depression, and comorbidities. Therefore,
the findings could be robust toward potentially resolving the issue of reverse causation. More-
over, this study conducted subgroup analyses, which provide evidence for heterogeneity by a
different socio-demographic characteristic. For example, we found the protective association of
being obese with cognitive function is stronger among the worse-off.
In conclusion, our results suggest that being obese, especially in late-life, is related to lower
risk of cognitive impairment, compared with having a normal weight. The reason for this
inverse association is unclear at present. Many different issues—such as diet, frailty, and body
composition change—could play a role. It is plausible that the role of BMI in dementia may
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change over the course of life. Further investigation is needed to understand the mechanism
and the public health consequences of these findings.
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